Authors/Disclosures
|
Robert F. Leroy, MD
|
No disclosure on file |
|
Roger J. Porter, MD, FAAN
|
Dr. Porter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axonis. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bright MInds Bioscience. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autobah. Dr. Porter has received publishing royalties from a publication relating to health care. |
|
Kimberly Robeson, MD, FAAN
(Albany Medical College)
|
Dr. Robeson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Robeson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. |
|
Martin Brodie
|
Martin Brodie has nothing to disclose. |
|
|
No disclosure on file |
|
Julie Varner, PhD
(GlaxoSmithKline)
|
No disclosure on file |
|
Kevan E. VanLandingham, MD, PhD, FAAN
(US Food and Drug Administration)
|
Dr. VanLandingham has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. VanLandingham has received stock or an ownership interest from Greenwich Biosciences. |
|
Sarah E. DeRossett, MD, PhD
|
No disclosure on file |